Dr. Lynch is a board-certified and fellowship-trained orthopedic surgeon, as well as a venture capitalist. Prior to joining Histogenics, she founded Advisorthopaedics.
Histogenics lead product line is NeoCart, a personalized cartilage tissue implant.
More Articles on Orthopedics:
Dr. Amanda Shepherd Joins Wake Forest Baptist Health-Lexington Medical Center
Joint Commission Awards PBMC Gold Seal of Approval for Hip, Knee Replacement
Kenmore Mercy Hospital Opens $5.4M Orthopedic Wing
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
